The role of surgeons in building a personalized medicine program
- 25 June 2014
- journal article
- review article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 111 (1) , 3-8
Abstract
Changes in technology, with decreases in the cost of molecular profiling, has expanded the interest in creating institution‐wide personalized medicine platforms to allow selective assessment of a given patient's tumor in real time, with the ability to utilize that information for patient‐care decisions. In order for this approach to function adequately, a multidisciplinary team must be created in an environment with dedicated support at an institutional level. J. Surg. Oncol. 2015 111:3–8.Keywords
Funding Information
- National Cancer Institute (T32 CA009599)
- Sheikh Khalifa Al Nahyan Ben Zayed Institute for Personalized Cancer Therapy
- Cancer Center Support Grant (CCSG P30 CA016672)
- National Center for Research Resources grants (3UL1RR024148)
This publication has 28 references indexed in Scilit:
- The CR3 motif of Rrp44p is important for interaction with the core exosome and exosome functionNucleic Acids Research, 2012
- Circulating tumour cells in non-metastatic breast cancer: a prospective studyThe Lancet Oncology, 2012
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through METNature Medicine, 2012
- Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysisThe Lancet Oncology, 2011
- Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst DevelopmentScience Translational Medicine, 2011
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E MutationNew England Journal of Medicine, 2011
- Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon CancerJournal of Clinical Oncology, 2009
- Circulating microRNAs as stable blood-based markers for cancer detectionProceedings of the National Academy of Sciences, 2008
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004